Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00474019
Status:
COMPLETED
Last Update Posted:
2010-12-03
First Post:
2007-05-14
Brief Title:
Phase 1 Pharmacokinetics of Intravenous Nexium in Children
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
D9615C00021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Tore Lind MD Nexium GI Established Brands Medical Science Director
Old Organization:
AstraZeneca Pharmaceuticals